Identification of surface antigens of Moraxella catarrhalis as targets of human serum antibody responses in chronic obstructive pulmonary disease.
about
Current progress with Moraxella catarrhalis antigens as vaccine candidatesThe Moraxella catarrhalis autotransporter McaP is a conserved surface protein that mediates adherence to human epithelial cells through its N-terminal passenger domain.Moraxella catarrhalis acquisition, airway inflammation and protease-antiprotease balance in chronic obstructive pulmonary disease.Outer membrane porin M35 of Moraxella catarrhalis mediates susceptibility to aminopenicillinsVirulence-associated trimeric autotransporters of Haemophilus parasuis are antigenic proteins expressed in vivoHuman antibody response to outer membrane protein G1a, a lipoprotein of Moraxella catarrhalis.Antigenic specificity of the mucosal antibody response to Moraxella catarrhalis in chronic obstructive pulmonary disease.Use of the chinchilla model for nasopharyngeal colonization to study gene expression by Moraxella catarrhalisRegions important for the adhesin activity of Moraxella catarrhalis HagMoraxella catarrhalis outer membrane protein CD elicits antibodies that inhibit CD binding to human mucin and enhance pulmonary clearance of M. catarrhalis in a mouse modelSerum antibody response to Moraxella catarrhalis proteins OMP CD, OppA, Msp22, Hag, and PilA2 after nasopharyngeal colonization and acute otitis media in childrenVaccine development for non-typeable Haemophilus influenzae and Moraxella catarrhalis: progress and challenges.Vaccine targets against Moraxella catarrhalis.Use of the Chinchilla model to evaluate the vaccinogenic potential of the Moraxella catarrhalis filamentous hemagglutinin-like proteins MhaB1 and MhaB2.Current progress of adhesins as vaccine candidates for Moraxella catarrhalis.Phagocytic dysfunction of human alveolar macrophages and severity of chronic obstructive pulmonary disease.Use of Moraxella catarrhalis lipooligosaccharide mutants to identify specific oligosaccharide epitopes recognized by human serum antibodies.Moraxella catarrhalis: from interactions with the host immune system to vaccine development.Moraxella Catarrhalis peritonitis.Moraxella catarrhalis expresses an unusual Hfq protein.A conserved tetranucleotide repeat is necessary for wild-type expression of the Moraxella catarrhalis UspA2 protein.Potential impact of a Moraxella catarrhalis vaccine in COPD.The immunogenicity of the liposome-associated outer membrane proteins (OMPs) of Moraxella catarrhalis.A Moraxella catarrhalis vaccine to protect against otitis media and exacerbations of COPD: an update on current progress and challenges.Comparison of the serological responses to Moraxella catarrhalis immunoglobulin D-binding outer membrane protein and the ubiquitous surface proteins A1 and A2.Intranasal vaccination with recombinant outer membrane protein CD and adamantylamide dipeptide as the mucosal adjuvant enhances pulmonary clearance of Moraxella catarrhalis in an experimental murine modelIdentification of domains of the Hag/MID surface protein recognized by systemic and mucosal antibodies in adults with chronic obstructive pulmonary disease following clearance of Moraxella catarrhalis.
P2860
Q28304447-F70ABA26-1501-48A1-A33A-850528680151Q30159574-4E34785A-6D2C-4E16-9B0D-13587AB6D129Q30884939-53A745B9-E6A1-4C6B-9638-8C98BA86B444Q33500328-9FFB5EB4-55F0-4D51-91F6-D23B7D532D5DQ33646169-174FAB27-1BA3-46A3-AA6E-AA65D84AFF61Q34033457-6C42C422-B38E-4694-88C1-B2ADA88E3BEBQ34194764-018D6AA7-9A33-4971-96C9-FFC94B86A107Q35805451-E87EBD06-10F5-4685-AAE2-EBC7E586F05AQ35910752-2743F289-FE74-4EA6-A821-AC8EC582E8C5Q35913382-264E1DED-8939-4FB5-9F39-BE6781600932Q36173789-FEA1A92B-75C9-452A-8EE6-0B39F97AD950Q36350568-BC9AE578-1B25-4C92-B8C5-29B9B713D6C7Q36483998-654DF7AC-F9B1-4976-A3CD-17DE30D2EF90Q36976255-C5BF014D-5F11-46DD-ACDE-E787814212CFQ37123450-087C3B58-0880-4C02-8C41-DB95EE889D8AQ37332198-86BEC40B-832E-4C73-B672-B1C450D3920BQ37355837-E959C4BA-CAF7-401D-93C3-E81CEB840190Q38041190-6D174A80-DEC9-4EB5-8B48-3E5009A9F04DQ38097431-672CFA4C-454E-46C9-A4DF-10BF3BC73FFAQ39023611-53D68BE9-795B-4FBD-A7E8-5861A6F59BC3Q39112669-280FCEA5-09B0-411C-BA4E-6D1158641097Q39129692-666902F3-5E2E-4A04-933D-3DBBBD9D15F6Q39936305-D7D13950-EC7B-4D44-AE7C-19F5FC63E489Q40074756-FFBBB27B-09BE-49F4-B5B7-66944504487DQ40289378-109FE06C-E821-4EF7-A8C5-09C4247BBAC5Q41836038-C26930DB-9916-4CA2-9B76-6A792B69C826Q41839685-8B0DCE53-72C8-4FEC-93F6-DD41C4E2BBBA
P2860
Identification of surface antigens of Moraxella catarrhalis as targets of human serum antibody responses in chronic obstructive pulmonary disease.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Identification of surface anti ...... obstructive pulmonary disease.
@en
type
label
Identification of surface anti ...... obstructive pulmonary disease.
@en
prefLabel
Identification of surface anti ...... obstructive pulmonary disease.
@en
P2093
P2860
P1476
Identification of surface anti ...... obstructive pulmonary disease.
@en
P2093
Aimee L Brauer
Christoph Aebi
Sanjay Sethi
P2860
P304
P356
10.1128/IAI.73.6.3471-3478.2005
P407
P577
2005-06-01T00:00:00Z